Skip to Content

Texas Center for Cancer Nanomedicine

The Texas Center for Cancer Nanomedicine (TCCN) is an NCI-funded multi-institutional, multidisciplinary center of excellence established with the collaborative efforts of The University of Texas Health Science Center at Houston (UTHSC-H), The University of Texas M.D. Anderson Cancer Center, The Methodist Hospital Research Institute (TMHRI), Duke University, Albert Einstein College of Medicine and University of New Mexico to develop and translate nanotechnology-enabled innovation for improving the traditionally dismal outcome of ovarian and pancreatic cancers.

The main research focus areas of the TCCN are:

  • Multifunctional nano-therapeutics, post-therapy monitoring tools and devices, and techniques for cancer prevention and control.
  • Early diagnosis using in-vitro assays and devices and in-vivo imaging techniques.

See Texas Center for Cancer Nanomedicine members


© 2014 The University of Texas MD Anderson Cancer Center